Drugmaker set to profit from an opioid it said was unsafe

WGNO-Oct 30, 2017

Endo contended that the new Opana ER and its hard coating deterred abuse, but this summer, the FDA disagreed. In June, the regulatory agency concluded that ...

Endo to receive royalties from generic opioid it once called 'unsafe ...
Becker's Hospital Review-21 hours ago

View all